Natco Pharma's Vishakapatanam unit issued 2 observations by USFDA

Natco Pharma's Vishakapatanam unit issued 2 observations by USFDA

According to Natco Pharma, the business is certain that it can address every observation in the allotted period

FPJ Web DeskUpdated: Saturday, February 04, 2023, 03:58 PM IST
article-image
Natco Pharma's Vishakapatanam unit issued 2 observations by USFDA | Image: Natco Pharma (Representative)

Natco Pharma Ltd today said that the US Food and Drug Administration has issued two observations to its formulation facility in Ramky SEZ, in Visakhapatnam after the regulator conducted an inspection, in an exchange filing.

"At the end of the inspection, the facility received two observations, one on written production process control procedure and the other on investigation procedure," the company said in the filing.

The inspection took place from January 30 to February 3. According to Natco Pharma, the business is certain that it can address every observation in the allotted period.

The pharmaceutical business in Hyderabad creates, produces, and markets completed dosage formulations and active pharmaceutical components in nations including India, the US, and Europe.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Income tax return filing: How to file ITR-1 Sahaj and the documents required

Income tax return filing: How to file  ITR-1 Sahaj and the documents required

REC subsidiaries transfer 6 projects to Power Grid Corporation

REC subsidiaries transfer 6 projects to Power Grid Corporation

UltraTech Cement announces allotment of 2,000 equity shares

UltraTech Cement announces allotment of 2,000 equity shares

Delhi Budget 2023 top highlights: FM Kailash Gahlot allocates ₹ 9,742 cr to health sector

Delhi Budget 2023 top highlights: FM Kailash Gahlot allocates ₹ 9,742 cr to health sector

Angel One Limited declares 4th interim dividend for FY23

Angel One Limited declares 4th interim dividend for FY23